Carregando...
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
Glioblastoma (GBM) is one of the deadliest human cancers. Because of the extremely unfavorable prognosis of GBM, it is important to develop more effective diagnostic and therapeutic strategies based on biologically and clinically relevant subclassification systems. Analyzing a collection of seventee...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Principais autores: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4746700/ https://ncbi.nlm.nih.gov/pubmed/26857460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep21557 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|